---
title: Lowering LDL Cholesterol, Masterclass Series & More In December's Monthly Beat
---

 Approval, Clinical Highlights & More in November's Monthly Beat

| View in browser DECEMBER Industry Updates New England Journal of Medicine Polypill with or without Aspirin in Persons without Cardiovascular Disease   The Lancet Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomized controlled trials   New England Journal of Medicine Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure   JAMA Internal Medicine Time to Benefit of Statin Therapy for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years   The Lancet Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomized, open-label, phase 3b trial   New England Journal of Medicine Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease     Clinical Highlights Review highlights from the recent CMHC Masterclass Read More     Featured Recipe Read More   Coming Soon: CMHC Masterclass   Addressing the NAFLD/NASH Epidemic: Advances in Pathophysiology, Diagnosis and Management   January 8-9, 2021 What to Expect   Addressing Cardiometabolic Risk in Children and Adolescents: Challenges and Solutions   January 28-29, 2021 What to Expect   Best Blog Read More       Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700 Unsubscribe Manage preferences |
| --- |